Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 9,543,485,600
  • Market Capitalization, $K 9,543,486
  • Shares Outstanding, K 70,800
  • 60-Month Beta 1.19
  • Price/Earnings ttm 20.64
  • Annual Dividend & Yield 0.31 (0.23%)
  • Most Recent Dividend 0.127 on 06/15/20
  • Management Fee 0.47%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.68 +0.15%
on 08/11/20
146.53 -10.00%
on 07/20/20
-7.33 (-5.27%)
since 07/10/20
3-Month
125.18 +5.35%
on 06/12/20
146.53 -10.00%
on 07/20/20
-2.02 (-1.51%)
since 05/11/20
52-Week
92.15 +43.11%
on 03/16/20
146.53 -10.00%
on 07/20/20
+26.40 (+25.03%)
since 08/09/19

Most Recent Stories

More News
How Will Biotech ETFs React to Q2 Earnings Release?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q2 earnings releases amid the coronavirus crisis.

BIIB : 289.94 (-3.44%)
ALXN : 101.24 (-0.63%)
GILD : 68.10 (-0.60%)
AMGN : 234.65 (-1.48%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 59.03 (-2.02%)
REGN : 598.86 (-1.54%)
AMGN : 234.65 (-1.48%)
SRPT : 158.03 (-0.61%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
Red Hot ETF Areas Amid the Coronavirus Crisis

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
PNQI : 189.52 (-1.66%)
FBT : 162.26 (-1.39%)
ARKW : 96.10 (-2.21%)
FDN : 179.83 (-1.74%)
ESGU : 75.40 (-0.85%)
ESGV : 60.84 (-0.83%)
OGIG : 40.10 (-1.50%)
USSG : 30.13 (-0.63%)
Moderna Turns Red Hot: Biotech ETFs to Bet On

Moderna skyrocketed 245% since it announced its COVID-19 vaccine candidate mRNA-1273 on Feb 10. The solid run is likely to continue as most of the analysts are optimistic on the stock.

MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
CNCR : 25.89 (-1.62%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
BTEC : 44.11 (-2.96%)
IDNA : 37.47 (-2.37%)
GERM : 30.07 (-6.03%)
Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

JNJ : 146.97 (-0.72%)
AZN : 55.18 (-0.36%)
PFE : 37.79 (-1.56%)
MRNA : 68.97 (-4.22%)
NVAX : 149.48 (-16.26%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
ARKG : 56.25 (-3.60%)
Fight the Spurt in Coronavirus Cases With These ETFs

Here we discuss some ETFs that investors can add to their portfolios amid the worsening coronavirus crisis.

IBB : 131.88 (-2.22%)
IBUY : 88.13 (-2.60%)
BOTZ : 26.36 (+0.23%)
CLOU : 21.26 (-2.34%)
Stocks Rise Again Amid Vaccine, Stimulus News

Stocks Rise Again Amid Vaccine, Stimulus News

LOVE : 30.84 (-4.84%)
TPB : 29.80 (-0.67%)
SUM : 17.50 (+0.75%)
XBI : 109.38 (-3.98%)
IBB : 131.88 (-2.22%)
VNQ : 81.33 (-1.44%)
PFE : 37.79 (-1.56%)
MSFT : 203.38 (-2.34%)
TSLA : 1,374.39 (-3.11%)
Biotech ETFs to Gain on Coronavirus Vaccine Progress

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

AZN : 55.18 (-0.36%)
MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
ARKG : 56.25 (-3.60%)
4 ETF Areas to Keep Soaring as Coronavirus Cases Rise

In the current scenario, the rising work-from-home and online shopping trend, increasing digital payments, growing video streaming and soaring video game sales are slowly becoming the "new normal."

IBB : 131.88 (-2.22%)
HACK : 47.83 (-1.36%)
XBI : 109.38 (-3.98%)
CIBR : 34.64 (-0.83%)
IBUY : 88.13 (-2.60%)
BOTZ : 26.36 (+0.23%)
SKYY : 74.89 (-1.24%)
CLIX : 85.73 (-2.40%)
ROBT : 37.69 (-0.60%)
CLOU : 21.26 (-2.34%)
Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

PFE : 37.79 (-1.56%)
MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
CNCR : 25.89 (-1.62%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
BTEC : 44.11 (-2.96%)
IDNA : 37.47 (-2.37%)
GERM : 30.07 (-6.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 135.97
1st Resistance Point 133.93
Last Price 131.88
1st Support Level 130.76
2nd Support Level 129.63

See More

52-Week High 146.53
Last Price 131.88
Fibonacci 61.8% 125.76
Fibonacci 50% 119.34
Fibonacci 38.2% 112.92
52-Week Low 92.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar